H. Kim

发表

Clinicopathological characteristics of T1 colorectal cancer without background adenoma

J. Oh, H. Chang, D. Sohn, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Prevalence of non-tuberculous mycobacteria in a hospital environment.

Eun Jung Lee, J. Shin, Chulhun L. Chang, 2007, The Journal of hospital infection.

A new aortoiliac calcification scoring system to predict grade C anastomotic leak following rectal cancer surgery

S. Y. Lee, Y. J. Kim, H. Kim, 2020, Techniques in Coloproctology.

Clinical features and treatment outcomes of advanced stage primary hepatic angiosarcoma.

Y. N. Park, J. Roh, S. Rha, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term Results of Thoracoscopic Thymectomy for Thymoma without Myasthenia Gravis

J. Chung, D. H. Lee, H. Kim, 2012, The Journal of international medical research.

Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced non-squamous non-small cell lung cancer.

M. Nishio, N. Yamamoto, T. Tamura, 2021, Annals of Oncology.

LBA54 Randomized phase III trial of nivolumab in combination with carboplatin, paclitaxel, and bevacizumab as first-line treatment for patients with advanced or recurrent non-squamous NSCLC

Teruhiko Yoshida, Y. Ohe, M. Nishio, 2020 .

FP03.02 Interim Analysis of Neoadjuvant Chemoradiotherapy and Durvalumab for Potentially Resectable Stage III Non-Small Cell Lung Cancer (NSCLC)

B. Cho, C. Lee, H. Yoon, 2021 .

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.

B. Cho, E. Shin, S. Park, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases.

J. Roh, S. Noh, S. Rha, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study.

R. Govindan, Keunchil Park, S. Peters, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Internal hernia following laparoscopic colorectal surgery: a rare but fatal complication

S. Y. Lee, Y. J. Kim, H. Kim, 2017, Hernia.

PCR amplification and sequence analysis of irido‐like virus infecting fish in Korea

T. Choi, H. Kim, Y. J. Kim, 2002 .

ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma

B. Cho, S. Yoon, M. Hong, 2018, Oncogene.

Clinical activity and safety of HM61713, an EGFR-mutant selective inhibitor, in advanced non-small cell lung cancer (NSCLC) patients (pts) with EGFR mutations who had received EGFR tyrosine kinase inhibitors (TKIs).

Keunchil Park, Dong-Wan Kim, Dae-Ho Lee, 2014 .

Comparison of clinical outcomes after conservative and surgical treatment of isolated anastomotic leaks after esophagectomy for esophageal cancer.

S. R. Kim, D. H. Lee, H. Kim, 2013, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).

Y. Im, S. Im, K. Jung, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Vertical transumbilical incision versus left lower transverse incision for specimen retrieval during laparoscopic colorectal surgery

J. Huh, Y. J. Kim, Yeo-Kyeoung Kim, 2013, Techniques in Coloproctology.

Umbilical incision laparoscopic colectomy with one additional port for colorectal cancer

J. Huh, Y. J. Kim, S. W. Lim, 2013, Techniques in Coloproctology.

Anti-adhesive Agent (Guardix-SGⓇ) Does Not Influence the Drainage Volume after Thyroid Cancer Surgery

Hang-Seok Chang, Yong Sang Lee, C. Park, 2013 .

Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.

M. S. Lee, Y. Kim, D. Ahn, 2000, International journal of oncology.

Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma

S. Paik, M. Ahn, B. Cho, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Molecular landscape of osimertinib resistance revealed by targeted panel sequencing and patient-derived cancer models in non-small cell lung cancer patients.

J. Barrett, S. Heo, B. Cho, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II trial of preoperative chemoradiotherapy and pembrolizumab for locally advanced esophageal squamous cell carcinoma (ESCC)

J. Kim, B. Cho, C. Lee, 2019, Annals of Oncology.

Activation of the Met kinase confers acquired drug resistance in FGFR-targeted lung cancer therapy

B. Cho, M. Ocker, P. Ellinghaus, 2016, Oncogenesis.

Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial

S. Gettinger, M. Ahn, R. Camidge, 2019, Annals of Oncology.

P76.18 Tissue- and Plasma-Based Landscape of Resistance to Osimertinib

S. Heo, B. Cho, A. Markovets, 2021 .

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.

B. Cho, H. Shim, E. Shin, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer.

J. Huh, Y. Jeong, Y. J. Kim, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Biological properties and expression of mucins in 5-fluorouracil resistant HT29 human colon cancer cells.

Y. Kim, D. Ahn, H. Kim, 2000, International Journal of Oncology.

MA26.09 Lazertinib, a Third Generation EGFR-TKI, in Patients with EGFR-TKI-Resistant NSCLC: Updated Results of a Phase I/II Study

Dohoung Kim, Y. Min, S. Shin, 2018, Journal of Thoracic Oncology.

Laparoscopic surgical repair of refractory chylous ascites after laparoscopic anterior resection

S. Y. Lee, Y. J. Kim, H. Kim, 2019, Techniques in Coloproctology.

1254P Efficacy and safety of tepotinib in patients (pts) with advanced age: VISION subgroup analysis of pts with MET exon 14 (METex14) skipping NSCLC

E. Smit, P. Paik, J. Mazières, 2021, Annals of Oncology.

Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial.

S. Gettinger, M. Ahn, D. Camidge, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

1782MO Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC

C. Rudin, M. Pietanza, J. Mazières, 2020 .

OA10.06 A First-in-Human Phase 1 Trial of the EGFR-cMET Bispecific Antibody JNJ-61186372 in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

M. Ahn, B. Cho, R. Knoblauch, 2018, Journal of Thoracic Oncology.

Ceritinib in ROS1-rearranged non-small-cell lung cancer: a Korean nationwide phase II study

M. Ahn, E. Cho, B. Cho, 2016 .